R&D | March 29, 2026
Rocket Pharma gets FDA nod for first pediatric gene therapy targeting severe LAD-I
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
Call it a major breakthrough for diagnostic imaging
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA
The FDA classified LifeVac as a Class II medical device
The approval comes after a systematic review of published literature
The FDA decision was based on results from the pivotal POETYK PsA-1 and POETYK PsA-2 Phase 3 trials
Subscribe To Our Newsletter & Stay Updated
